Shopping Cart
- Remove All
- Your shopping cart is currently empty
Istaroxime is an effective inhibitor of Na+, K+-ATPase (IC50: 0.11 μM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | Istaroxime is an effective inhibitor of Na+, K+-ATPase (IC50: 0.11 μM). |
Targets&IC50 | Na+, K+-ATPase:0.11 μM |
In vitro | Istaroxime inhibits the Na+/K+-ATPase activity from the dog kidney (IC50: 0.43 ± 0.15 μM). Istaroxime acting as a positive inotropic compound through the inhibition of the Na+, K+-ATPase[2]. Inhibition of Na+/K+-ATPase activity in preparations from guinea pig kidney yielded potencies of 8.5 μM for PST2744[3]. |
In vivo | Istaroxime (PST2744) causes a progressive to enhance in +dP/dtmax throughout the infusion. That reaches 80% (ED80) at the cumulative dose of 1.89±0.37 mg/kg and a peak of 140±3.5% at the dose (EDmax) of 4.88±0.6 mg/kg[3]. |
Alias | PST2744 |
Molecular Weight | 360.49 |
Formula | C21H32N2O3 |
Cas No. | 203737-93-3 |
Relative Density. | 1.34 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.